Pharmaceutical stocks slumped after President Donald Trump sent letters to 17 drugmakers with an ultimatum to reduce drug ...

Explore market-impacting Trump administration moves, from drug pricing reforms targeting pharma giants to Swiss tariff hikes.

JNJ edges out AZN following Q2 results with raised guidance, stronger estimate revisions and a more attractive valuation.

Shares of European drugmakers slipped on Friday after U.S. President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the United States, months after signing a sweeping ...

Investing.com - Shares of European drugmakers fell on Friday after President Donald Trump issued letters to more than a dozen ...

Shares of European pharmaceutical companies sold off on Friday after President Donald Trump issued letters to 17 companies, ...

President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S.

President Donald Trump has sent letters to the CEOs of 17 pharmaceutical companies demanding action to address high ...

Teva Pharmaceutical Industries TEVA reported second-quarter 2025 adjusted earnings of 66 cents per share, which beat the ...

President Donald Trump sent letters to 17 leading pharmaceutical manufacturers, including Eli Lilly (NYSE:LLY), Pfizer ...

The Trump administration has proposed a pilot initiative to address controversy over the 340B drug discount program.